Abstract
Kaposi sarcoma (KS), in addition to being the most common malignancy among people with AIDS in the USA. [1], has become the most common malignancy overall in entire countries of sub-Saharan Africa [2,3]. AIDS KS prognosis has greatly improved with highly active antiretroviral therapy (HAART) [4], but this tumor is still a major cause of disfigurement, other morbidities, and mortality [4,5].
Original language | English |
---|---|
Pages (from-to) | 1637-1639 |
Number of pages | 3 |
Journal | AIDS |
Volume | 21 |
Issue number | 12 |
DOIs | |
Publication status | Published - 31 Jul 2007 |
Bibliographical note
We acknowledge the support offered by the Research and Development Office, Northern Ireland who funded L.A.A. in the Cancer Prevention Fellowship Program at the National Cancer Institute.Keywords
- Africa
- Antiviral therapy
- Cancer chemotherapy
- HIV/AIDS
- Human herpesvirus 8
- Kaposi sarcoma
- Transplantation
- Virus load